Mankind Pharma Share Allotment: Mankind Pharma’s share allotment is expected to take place on May 3, wherein investors will get shares on a lottery basis. The registrar will supervise the entire process. However, once Mankind Pharma IPO The allotment is announced, the bidder need not wander around. A bidder can check his/her Mankind Pharma IPO allotment status online by logging into the BSE website or the website of its official registrar – Kefin Technologies Limited.
Members can refer to the following two direct links and find out whether their IPO shares have been allotted or not.
https://www.bseindia.com/investors/appli_check.aspx
https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp
How to check Mankind Pharma IPO allotment status on BSE
1]Login directly to BSE link – bseindia.com/investors/appli_check.aspx;
2]Select ‘Equity’ in the issue type;
3]Enter whatever application number or PAN number you have;
4]Click on ‘I am not a robot’; And
5]Click on the ‘Search’ button.
Your Mankind Pharma IPO Allotment Status will be available on your computer monitor on the display of your cell phone.
How to check Mankind Pharma IPO allotment status on Kfintech
1]Login directly to the Kfintech website — kprism.kfintech.com/ipostatus;
2]Select ‘Mankind Pharma IPO’;
3]Select ‘Application Number’, ‘Demat Account’ or PAN (For convenience, here we are taking Application Number);
4]Enter Application Number;
5]Enter the captcha; And
6]Click on the ‘Submit’ option at the bottom.
Your Mankind Pharma IPO Allotment Status will be available on your computer monitor on the display of your cell phone.
Mankind Pharma IPO GMP
As per the reports, the latest GMP of Mankind Pharma suggests a premium of Rs 92, suggesting that the stock will make a good debut if listed on the stock market.
Mankind Pharma will finalize the allotment of shares on May 3, 2023. Refunds will be issued from May 4 onwards if the customers have not already got the allotment. The shares after allotment will be credited to the demat account of the clients on May 5. Following the public subscription, the shares of Mankind Pharma are expected to go live on the stock exchanges on May 8, 2023.
Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India are the book-running lead managers to the issue.
About Mankind Pharma IPO
By December 2022, Mankind Pharma is the fourth largest Indian pharmaceutical company in terms of domestic sales and the third largest in terms of sales volume.
Mankind Pharma’s Rs 4,326 crore initial share sale, which is a fully fledged offer for sale (OFS), was subscribed nearly 15.32 times, driven by strong interest from qualified institutional buyers (QIBs).
QIB portion was subscribed 49 times, NII bit was subscribed 3.8 times. Retail investors did not show much interest as the subscription to their portion was less than 100%.
read all latest business news, tax news And stock market update Here
